Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
Go to Source
2023-04-27 19:56
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
